Securities Law

As Capital Edge marks 16 years by reaffirming its niche focus, we explore the explosive growth of specialized consulting driven by byzantine federal rules.

Society22 PR's top IR award highlights a new playbook for market trust, where navigating AI and complex regulatory shifts has become paramount.

Zhongchao Inc. seeks $5M in a 'best efforts' deal, but the move sends its stock plummeting over 50% as investors weigh dilution and delisting risks.

In a historic move, the SEC has approved Paxos as the first blockchain-native clearing agency, signaling a major shift for Wall Street's core infrastructure.

The metal recycler faces a potential delisting after a second notice from Nasdaq for failing to file financial reports, raising concerns for investors.

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

After a record stock plunge, Planet Fitness is under investigation for misleading investors with rosy forecasts that masked serious operational headwinds.

Smart Props Solution launches a blockchain platform offering fractional real estate ownership for as little as $100, but navigating this new frontier has risks.

As summer begins, the CAA urges Canadians to plan safe rides, citing new data on the underestimated dangers of cannabis-impaired driving on our roads.

Trusted Advisor Search, led by a 40-year industry veteran, launches with a new model embedding legal counsel to protect advisors from career-move pitfalls.

Singapore's TechCreate reports 54% revenue growth and a quantum tech leap, but a regulatory trading halt has left investors and the market in the dark.

A federal judge has denied Binance and its ex-CEO's attempt to force arbitration, allowing a billion-dollar securities class action to proceed in court.

FDA approves the first generic of a vital nutrition drug, granting Apotex a 180-day exclusive edge and signaling major cost savings for healthcare.

Facing a shareholder revolt after a damning indictment, Supermicro launches a major probe into a $2.5B shadow trade scheme. Is it too little, too late?

The new algorithm aims to systematically filter out harmful interactions and reduce hidden trading costs in the complex world of off-exchange trading.

With new clinical trial data showing its AI is superior for complex AFib, Volta Medical heads to a major conference to change the standard of care.

Willow Lane's merger with AI cloud provider Boost Run is on hold pending SEC approval, highlighting regulatory hurdles in the high-stakes GPU compute race.

American Ventures publicizes support from 85+ investors, a move to counter a recent fraud lawsuit and an ongoing SEC investigation into its practices.